comparemela.com

Latest Breaking News On - Prof van cutsem - Page 1 : comparemela.com

Cantargia AB: Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day focusing on new clinical results and biomarker data for

Region flamandeDavid libergVan cutsemDominique tersagoEric van cutsemPrnewswire cantargiaUniversity hospitals gasthuisbergVp researchUniversity of warsawBelgian foundationNasdaq stockholmDivision headDigestive oncologyEric vanMedical universityProf van cutsem

Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today.

Region flamandeVan cutsemEric van cutsemPhderic van cutsemDominique tersagoDavid libergPrnewswire cantargiaUniversity hospitals gasthuisbergVp researchBelgian foundationUniversity of warsawNasdaq stockholmDivision headDigestive oncologyEric vanMedical university

Cantargia AB: Cantargia to host R&D Day on nadunolimab combinational synergy in pancreatic cancer and non-small cell lung cancer

STOCKHOLM, June 9, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day on Thursday, June 16, 2022 at 09:00 AM EDT (3:00 PM CET), focusing

Region flamandeUnited statesLos angelesSudheer dossPrnewswire cantargiaLuniversidad complutenseLuis pazEric van cutsemVan cutsemUniversity of californiaBelgian foundationUniversity of warsawOncology departmentUniversity hospitals gasthuisbergNational oncology research centerPancreatic cancer action network pan

Cantargia to host R&D Day on nadunolimab combinational synergy in pancreatic cancer and non-small cell lung cancer

/PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day on Thursday, June 16, 2022 at 09:00 AM EDT (3:00 PM.

Region flamandeUnited statesLos angelesSudheer dossLuniversidad complutenseLuis pazEric van cutsemVan cutsemUniversity of californiaBelgian foundationUniversity of warsawOncology departmentUniversity hospitals gasthuisbergNational oncology research centerPancreatic cancer action network panNasdaq stockholm

vimarsana © 2020. All Rights Reserved.